tiprankstipranks
Provectus Pharmaceuticals (PVCT)
OTHER OTC:PVCT
US Market
Holding PVCT?
Track your performance easily

Provectus Pharmaceuticals (PVCT) Financial Statements

79 Followers

Provectus Pharmaceuticals Financial Overview

Provectus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.007; its P/E ratio is -17.78; Provectus Pharmaceuticals is scheduled to report earnings on May 9, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 109.75K$ 254.99K$ 238.07K-$ 161.84K
Gross Profit$ 109.75K$ 254.99K$ 238.07K$ 69.73K$ 161.84K
EBIT$ -955.67K$ -785.55K$ -447.26K$ -714.32K$ -784.24K
EBITDA$ -953.44K$ -783.32K$ -445.03K$ -712.09K$ -782.01K
Net Income Common Stockholders$ -1.01M$ -846.85K$ -504.04K$ -775.80K$ -835.06K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 187.46K$ 29.58K$ 18.04K$ 367.25K$ 176.01K
Total Assets$ 802.03K$ 856.43K$ 1.08M$ 1.69M$ 1.69M
Total Debt$ 148.26K$ 159.84K$ 252.66K$ 937.93K$ 319.48K
Net Debt$ -39.20K$ 130.26K$ 234.62K$ 570.68K$ 143.47K
Total Liabilities$ 6.22M$ 8.37M$ 5.43M$ 9.21M$ 8.98M
Stockholders Equity$ -5.42M$ -7.51M$ -7.46M$ -7.52M$ -7.30M
Cash Flow-
Free Cash Flow$ -565.00K$ -762.59K$ -1.04M$ -768.87K$ -617.78K
Operating Cash Flow$ -565.00K$ -762.59K$ -1.04M$ -768.87K$ -617.78K
Investing Cash Flow-----
Financing Cash Flow$ 589.40K$ 588.95K$ 781.10K$ 817.86K$ 656.44K
Currency in USD

Provectus Pharmaceuticals Earnings and Revenue History

Provectus Pharmaceuticals Debt to Assets

Provectus Pharmaceuticals Cash Flow

Provectus Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis